Rethinking Parkinson's Staging

This chapter explores the challenges and implications of new biological staging criteria for Parkinson's disease, focusing on research versus clinical application. The discussion emphasizes inclusivity, the involvement of stakeholders, and careful consideration of regulatory requirements to ensure equitable access to care and research opportunities.